Applied Physics Laboratory

Reveal Technology, Inc. Receives $3.2M Award With U.S. Marine Corps Warfighting Laboratory (MCWL)

Retrieved on: 
Thursday, March 28, 2024

BOZEMAN, Mont., March 28, 2024 /PRNewswire/ -- Reveal Technology, Inc. (Reveal), is proud to share that they have been granted a $3.2M research, development, testing and evaluation (RDT&E) contract award with the Marine Corps Warfighting Laboratory (MCWL).

Key Points: 
  • BOZEMAN, Mont., March 28, 2024 /PRNewswire/ -- Reveal Technology, Inc. (Reveal), is proud to share that they have been granted a $3.2M research, development, testing and evaluation (RDT&E) contract award with the Marine Corps Warfighting Laboratory (MCWL).
  • In support of the overarching force design goals of investing in unmanned aircraft systems and applied artificial intelligence (AI), Reveal will provide integrated AI-enhanced ISR capabilities for Marine Corps experimentation via the Farsight application.
  • We're looking forward to working with our project stakeholders to revolutionize Marine Corp ISR using cutting-edge computer vision and AI," said Garrett Smith, CEO of Reveal.
  • "Reveal understands the importance of autonomous capabilities in the next fight and looks forward to seeing its impact on joint all-domain operations."

Research Team Progresses to Final Phase in NIH Competition, Pioneering Autonomic Neuromodulation to Expand Applications for Spinal Stimulation

Retrieved on: 
Thursday, March 21, 2024

EAST HANOVER, N.J., March 21, 2024 /PRNewswire/ -- Marking significant progress towards improving the lives of individuals with spinal cord injuries, Kessler Foundation, University of Louisville, and John Hopkins Applied Physics Laboratory (with the support of Medtronic) have collaboratively won the $1,000,000 prize for Phase 2 of the Neuromod Prize for their project titled, "Neuromodulation of the lumbosacral spinal cord for improvement of autonomic function after spinal cord injury." With this win, the team advances to compete for the Phase 3 prize pool of $5 million.

Key Points: 
  • With this win, the team advances to compete for the Phase 3 prize pool of $5 million.
  • Phase 1 called for innovative therapy concepts and development plans, leading to Phase 2's proof-of-concept studies by the eight selected teams.
  • On February 27, 2024, the NIH announced the four Phase 2 victors, marking a breakthrough moment in neuromodulation research.
  • "Most importantly, what we are learning and sharing about neuromodulation through this Competition will influence new approaches to treating other types of disabling autonomic dysfunction."

GovExec and Nextgov/FCW Announce 2024 Federal 100 Winners

Retrieved on: 
Friday, February 9, 2024

WASHINGTON, Feb. 9, 2024 /PRNewswire/ -- GovExec, the market-leading sales and marketing intelligence company for government leaders and contractors, unveiled today the winners of the 2024 Federal 100 Awards. Renowned as the most prestigious awards for the federal IT community, the Fed 100 recognizes a range of leaders who have pushed government operations forward through innovative tech approaches. Coordinated by Nextgov/FCW, which provides federal technology executives with the information, ideas and strategies necessary to successfully navigate the complex world of federal business, the Fed 100 will be presented during GovExec's annual Evening of Honors Gala hosted for the first time at The Anthem in Washington DC on April 24, 2024.

Key Points: 
  • WASHINGTON, Feb. 9, 2024 /PRNewswire/ -- GovExec, the market-leading sales and marketing intelligence company for government leaders and contractors, unveiled today the winners of the 2024 Federal 100 Awards.
  • Renowned as the most prestigious awards for the federal IT community, the Fed 100 recognizes a range of leaders who have pushed government operations forward through innovative tech approaches.
  • From agency employees and members of the federal contracting sector to academics, independent watchdogs, and members of Congress, the Fed 100 is dedicated to reflecting the spectrum of changemakers driving the evolution of the federal IT space.
  • The 2024 winners include:
    James Adams - Johns Hopkins Applied Physics Laboratory, Department of Energy
    Steven Costa - Air Force/U.S.

ReAlta Life Sciences Strengthens Board of Directors with Appointment of Two Accomplished Biotechnology Innovators

Retrieved on: 
Wednesday, January 24, 2024

“We are delighted to welcome Dr. Baldoni and Dr. Van Gieson to our Board of Directors and look forward to their expertise as we continue to advance our EPICC platform beyond our current portfolio,” said Buzz Heidt, Chairman of ReAlta’s Board of Directors.

Key Points: 
  • “We are delighted to welcome Dr. Baldoni and Dr. Van Gieson to our Board of Directors and look forward to their expertise as we continue to advance our EPICC platform beyond our current portfolio,” said Buzz Heidt, Chairman of ReAlta’s Board of Directors.
  • Dr. Baldoni’s Platform Technology and Science team supported the development of small molecules, biopharmaceuticals and cell and gene therapy modalities from discovery through commercialization.
  • Dr. Baldoni stepped away from that leadership role in 2017 to start the first AI-driven drug discovery unit at GSK.
  • After retiring from GSK in 2019, he spent a year as the Chief Technology Officer of a stealth AI-enabled drug discovery startup.

DARPA Advances PsiQuantum to Second Phase of Utility-Scale Quantum Computing Program

Retrieved on: 
Tuesday, January 9, 2024

This program was envisioned by DARPA to include an escalating engagement over a multi-phase, multi-year effort.

Key Points: 
  • This program was envisioned by DARPA to include an escalating engagement over a multi-phase, multi-year effort.
  • The year-long government diligence effort determined that PsiQuantum’s photonic approach is worthy of elevating to the next phase of the US2QC program.
  • As the quantum computing industry has matured, it has become widely acknowledged that “utility-scale” commercially useful quantum computing requires large-scale systems and error correction.
  • As the PsiQuantum effort moves to the next phase, the focus will shift to PsiQuantum’s design for a fault-tolerant prototype.

Dr. Paul Stockton Named Incoming ANSER Board Chair

Retrieved on: 
Tuesday, November 28, 2023

Dr. Stockton's appointment was announced by out-going Board Chairman, General Craig R. McKinley, USAF (Ret.

Key Points: 
  • Dr. Stockton's appointment was announced by out-going Board Chairman, General Craig R. McKinley, USAF (Ret.
  • Dr. Stockton also chairs the Homeland Defense and Defense Support to Civil Authorities subcommittee of DOD's Reserve Forces Policy Board and the Grid Resilience for National Security subcommittee of DOE's Electricity Advisory Committee.
  • Dr. Stockton also served as Executive Director of the US Council of Governors and led Department policy initiatives on continuity planning and antiterrorism/force protection.
  • Dr. Stockton leads a strategic advisory firm in Santa Fe, NM helping private sector and government leaders strengthen the resilience of U.S. infrastructure.

EXpressLO LLC Awarded U.S. Patent 11,808,679 for Cryo-EM Specimen Handling

Retrieved on: 
Tuesday, November 7, 2023

LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials. EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.

Key Points: 
  • EXpressLO LLC has been awarded U.S. Patent 11,808,679 from the USPTO for a unique cryogenic ex situ lift out specimen manipulation process for cryogenically prepared focused ion beam specimens.
  • LEHIGH ACRES, Fla., Nov. 7, 2023 /PRNewswire-PRWeb/ -- EXpressLO LLC was awarded U.S. Patent 11,808,679 from the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for cryo-EXLO manipulation of biological and beam sensitive materials.
  • EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques.
  • The novel methods and apparatus described in this U.S. patent were invented by EXpressLO LLC founder and President, Dr. Lucille A. Giannuzzi.

National Air and Space Museum's 2024 Michael Collins Trophy Awarded to Astronaut Peggy Whitson and the Double Asteroid Redirection Test Team

Retrieved on: 
Tuesday, November 7, 2023

WASHINGTON, Nov. 7, 2023 /PRNewswire/ -- The Smithsonian's National Air and Space Museum awards its Michael Collins Trophy annually for Lifetime and Current Achievements.

Key Points: 
  • WASHINGTON, Nov. 7, 2023 /PRNewswire/ -- The Smithsonian's National Air and Space Museum awards its Michael Collins Trophy annually for Lifetime and Current Achievements.
  • The renaming of the trophy in 2020 (previously the National Air and Space Museum Trophy) recognizes Apollo 11 astronaut Michael Collins' contributions to aerospace and his service to the museum as director during a critical time in its evolution.
  • "The 2024 Michael Collins Trophy recipients have made extraordinary impacts on the past, present and future of space exploration," said Chris Browne, the John and Adrienne Mars Director of the museum.
  • The National Air and Space Museum in Washington, D.C., is located at Sixth Street and Independence Avenue S.W.

Axis Research & Technologies Chief Operating Officer Jill Goodwin Selected Finalist for 2023 Stevie® Awards for Women in Business

Retrieved on: 
Tuesday, October 3, 2023

Established in 2002, the Stevie Awards stand as a premier global business award, recognizing accomplishments and positive contributions by organizations and professionals across the world.

Key Points: 
  • Established in 2002, the Stevie Awards stand as a premier global business award, recognizing accomplishments and positive contributions by organizations and professionals across the world.
  • Goodwin is among seven finalists for “Most Innovative Woman of the Year — Healthcare” and is recognized alongside the other healthcare leaders.
  • Over 1,600 nominations were submitted globally for this year’s Stevie® Awards for Women in Business across 100 categories.
  • “It is an honor to have been chosen as a finalist in this category amongst such accomplished businesswomen,” said Jill Goodwin, COO at Axis Research & Technologies.

Applied Intuition Wins Production Award to Deliver Synthetic Data for Aided Target Recognition (AiTR)

Retrieved on: 
Thursday, September 21, 2023

Through the engagement, Applied will generate high-fidelity synthetic data to train an algorithm designed to identify and track adversary systems.

Key Points: 
  • Through the engagement, Applied will generate high-fidelity synthetic data to train an algorithm designed to identify and track adversary systems.
  • By augmenting real-world data with high-fidelity synthetic data, autonomy development teams in the Air Force will be able to quickly expand their corpus of training data, improve model performance in identifying adversary threat systems, and accelerate development velocity and the delivery of game changing target recognition capabilities to the warfighter.
  • Additionally, Applied will share commercial best practices, tactics, and techniques for the employment and utilization of synthetic data to AFWERX to ensure program success.
  • "Aided target recognition is fundamentally a perception problem - something that we're very familiar with from our work in the commercial autonomous vehicle space.